LMNA and cardiomyopathy: It will thus be exciting to study the trafficking of other channels in cardiomyopathy caused by mutations in LMNA, which may help to identify novel therapeutic targets for cardiac disorders that arise from the deficient delivery of ion channels to the plasma membrane.